|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-10-25
|
|
pubmed:abstractText |
High-dose thiotepa has been successfully included in a variety of conditioning regimens for stem cell transplantation in hematological and solid neoplasms. Toxicity of high-dose thiotepa mainly manifests as profound myeloablation and some degree of liver damage. We report a case of inappropriate secretion of antidiuretic hormone (SIADH) in a patient with primary CNS lymphoma who underwent therapy with high-dose thiotepa.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0268-3369
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
571-2
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10482945-Adult,
pubmed-meshheading:10482945-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10482945-Brain Neoplasms,
pubmed-meshheading:10482945-Combined Modality Therapy,
pubmed-meshheading:10482945-Cranial Irradiation,
pubmed-meshheading:10482945-Female,
pubmed-meshheading:10482945-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10482945-Humans,
pubmed-meshheading:10482945-Inappropriate ADH Syndrome,
pubmed-meshheading:10482945-Lymphoma, Non-Hodgkin,
pubmed-meshheading:10482945-Thiotepa,
pubmed-meshheading:10482945-Transplantation Conditioning
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Inappropriate antidiuretic hormone secretion after high-dose thiotepa.
|
|
pubmed:affiliation |
Divisione Ematologia, Istituto di Semeiotica Medica, Università Cattolica Sacro Cuore, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
